Stay updated on Teclistamab Maintenance Combo vs Monotherapy Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Maintenance Combo vs Monotherapy Clinical Trial page.

Latest updates to the Teclistamab Maintenance Combo vs Monotherapy Clinical Trial page
- Check7 days agoChange DetectedEuropean Myeloma Network B.V. was added as sponsor/collaborator and the corresponding Contacts/Locations and Study Status sections were updated; Stichting European Myeloma Network and the former designation European Myeloma Network B.V. (Stichting European Myeloma Network) were removed.SummaryDifference0.7%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Record History now shows a new revision v3.3.2 and removes the previous v3.2.0 entry. This is a metadata update to the page history rather than changing trial data.SummaryDifference0.1%

- Check28 days agoChange DetectedThe funding/operating status notice banner at the top of the page was removed.SummaryDifference0.6%

- Check43 days agoChange DetectedNew screenshot shows minor updates to the Record History page, including added IPDSharing entries and small changes to Study Status/Contacts details. These alterations do not affect the core study data or the page's primary purpose.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a government funding notice and updated operating status guidance, a new date range and a newer revision version; removed an earlier date and older revision.SummaryDifference13%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to Teclistamab Maintenance Combo vs Monotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Maintenance Combo vs Monotherapy Clinical Trial page.